|
KMID : 1813520220110010001
|
|
Journal of the Korean Glaucoma Society
2022 Volume.11 No. 1 p.1 ~ p.11
|
|
|
Clinical Outcomes of Micropulse Transscleral Cyclophotocoagulation in Refractory
|
|
Park Sung-Eun
Seo Du-Ri
Choi Wung-Rak
Lee Sang-Yeop
Seong Gong-Je
Kim Chan-Yun
Bae Hyoung-Won
|
|
|
Abstract
|
|
|
Purpose : This study evaluated the clinical outcomes of first-time micropulse transscleral cyclophotocoagulation (MP-TSCPC) in patients with refractory glaucoma.
Methods : This retrospective study analyzed the patients with refractory glaucoma who underwent MP-TSCPC from February 2018 to February 2020 at Yonsei University Severance Hospital. A total of 54 eyes of 52 Asian patients (aged 55.67 ± 15.92 years) who underwent MP-TSCPC for the first time, were included in this study.
Results : The mean preoperative intraocular pressure (IOP) was 26.09 ± 8.75 mmHg. The most common diagnosis was primary open-angle glaucoma (44.4%) and secondary glaucoma (44.4%) with a mean logarithm of the minimum angle of resolution visual acuity of 1.06 ± 0.98 and 1.32 ± 1.00 respectively. There was a significant reduction (p<0.001) in IOP on 1 day, to 18.63 ± 6.47 mmHg; at 1 week, to 13.54 ± 5.26 mmHg; at 1 month, to 16.02 ± 5.63 mmHg; at 3 months, to 17.23 ± 5.29 mmHg; 6 months to 18.07 ± 6.30 mmHg; and 12 months, to 16.51 ± 5.41 mmHg. There was also a reduction (p<0.05) in the number of topical anti-glaucoma medications required to control IOP at 1, 3, 6, and 12 months.
Conclusions : MP-TSCPC is an effective procedure that offers good results in reducing IOP and decreases the use of anti-glaucoma medications in patients with refractory glaucoma.
|
|
|
KEYWORD
|
|
|
Glaucoma, Intraocular pressure, Laser coagulation
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|